Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $5.75 Million Public Offering and Nasdaq Uplisting of Silo Pharma, Inc.

Press Release – New York, NY – October 3, 2020 – Sichenzia Ross Ference LLP announced today that it represented Laidlaw & Company (UK) Ltd. in the $5.75 million initial public offering and Nasdaq uplisting of Silo Pharma, Inc. (Nasdaq: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. 1,150,000 shares of common stock, which included the full exercise of the underwriters’ over-allotment option, were sold to the public at a price of $5.00 per share. Silo Pharma’s common stock began trading on the Nasdaq Capital Market under the ticker symbol “SILO” on September 27, 2022.

Laidlaw & Company (UK) Ltd. acted as the sole book-running manager for the offering. The Benchmark Company, LLC acted as the co-manager for the offering.

The Sichenzia Ross Ference LLP team was led by partners Michael Ference and Barrett DiPaolo and associates Matt Siracusa and Kayla Scoccola.

Author
Recent Posts

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRFC's LinkedIn page

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

Sichenzia Ross Ference Carmel LLP Represents EF Hutton in the $4 Million Private Placement of Solidion Technology, Inc. - September 9, 2024
Sichenzia Ross Ference Carmel LLP Represents Joseph Gunnar & Co., LLC in $0.4 Million Registered Direct Offering of Eastside Distilling - September 6, 2024
Sichenzia Ross Ference Carmel LLP Represents Qualigen Therapeutics, Inc. in $3.47 Million Public Offering - September 6, 2024

Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $5.75 Million Public Offering and Nasdaq Uplisting of Silo Pharma, Inc.

Related Posts